News Breaks |
|
|
| November 12, 2012 |
| 10:00 EDT |  | NKTR, JCP, CAT, PBR, VRTX, KRC, GRMN, BMY, STRA, JNJ, IQNT, HES, VNO | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Caterpillar (CAT) downgraded to Neutral from Overweight at JPMorgan... Garmin (GRMN) downgraded to Sell from Neutral at Goldman... Inteliquent (IQNT) downgraded to Underweight from Equal Weight at Morgan Stanley... J.C. Penney (JCP) downgraded to Underperform from Neutral at Credit Suisse... Johnson & Johnson (JNJ) downgraded to Hold from Buy at Jefferies... Kilroy Realty (KRC) downgraded to Neutral from Buy at BofA/Merrill... Nektar (NKTR) downgraded to Hold from Buy at Jefferies... Strayer Education (STRA) downgraded to Neutral from Overweight at JPMorgan... Vertex (VRTX) downgraded to Neutral from Outperform at Credit Suisse... Vornado (VNO) downgraded to Neutral from Buy at BofA/Merrill... Bristol-Meyers (BMY) downgraded to Market Perform from Outperform at BMO Capital... Petrobras (PBR) downgraded to Neutral from Buy at BofA/Merrill... Hess Corp. (HES) downgraded to Market Perform from Outperform at Howard Weil. |
|
|
News For CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES From The Last 14 Days Check below for free stories on CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES the last two weeks. |
|
|
| May 23, 2013 |
| 10:08 EDT |  | JNJ | On The Fly: Analyst Initiation Summary
 Subscribe for More Information |
|
| 08:14 EDT |  | JNJ | Carter's
Global Consumer Products Analysts discuss the possibility of China retiring the one-child policy within the year and potential implications for consumer products on an Analyst/Industry conference call. Relevant covered companies JNJ, PG, PFE, ABT, KMB, MJN and CRI which may be impacted and discussed on the Analyst/Industry conference call to be held on May 23 at 10 am. |
|
| 07:31 EDT |  | JNJ | Janssen expects to have more than 25 brand line extensions by 2017
Subscribe for More Information |
|
| 06:29 EDT | | JNJ | Johnson & Johnson coverage assumed with an Underperform at Credit Suisse
Subscribe for More Information |
|
| 06:02 EDT |  | BMY | Bristol-Myers implied volatility at upper end of index mean range
|
|
| 05:47 EDT | | BMY | Stocks with implied volatility movement; SKS BMY
Stocks with implied volatility movement; Saks (SKS), Bristol-Myers (BMY) according to IVolatility. |
|
| May 22, 2013 |
| 16:12 EDT | | JCP | J.C. Penney enters into new $2.25B credit facility
J. C. Penney Company announced that its wholly owned subsidiary, J. C. Penney Corporation, has entered into a new five-year $2.25B senior secured term loan credit facility. The size of the facility was increased from the $1.75B anticipated in the commitment letter the company announced on April 29. |
|
| 16:00 EDT | | BMY, JNJ | Options Update; May 22, 2013
Subscribe for More Information |
|
| 10:33 EDT | | BMY | Bristol-Myers jumps after Citi ups rating on cancer potential
Subscribe for More Information |
|
| 10:16 EDT |  | BMY | Bristol-Myers spikes higher following upgrade, levels to watch
Subscribe for More Information |
| |
| 10:00 EDT |  | BMY | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:42 EDT | | CAT | Senate Committee on Foreign Relations to hold a hearing
The Committee holds a hearing entitled, "Different Perspectives on International Development" with Director of International Governmental Affairs Lane of Caterpillar (CAT) on May 22 at 10:30 am. Webcast Link |
|
| 06:05 EDT | | BMY | Bristol-Myers upgraded to Buy from Neutral at Citigroup
Subscribe for More Information |
|
| 06:01 EDT | | HES | Hess Corp. implied volatility at lower end of index mean range
|
|
| May 21, 2013 |
| 10:22 EDT |  | CAT | Caterpillar to resume talks with steelworkers, WSJ says
Subscribe for More Information |
|
| 09:29 EDT | | NKTR | AstraZeneca says Phase III studies of Naloxegol met primary, secondary endpoints
AstraZeneca (AZN) presented the results of two pivotal Phase III studies of naloxegol showing the 25 mg dose of the investigational drug met its primary and secondary endpoints for efficacy and showed a safety profile consistent with previous studies. Data was presented at the Digestive Disease Week meeting in Orlando, Florida. The primary endpoint in both trials was percentage of OIC responders, versus placebo, over 12 weeks of treatment. The secondary endpoints included the 12-week response rate in a laxative inadequate response population, the median time to first spontaneous bowel movement and the number of days per-week with at least one bowel movement. Plans for naloxegol will be finalized over the coming months, incorporating the outcome of ongoing discussions with health authorities in the US, EU and Canada, the company said. Naloxegol, a peripherally-acting mu-opioid receptor antagonist, has been specifically designed for the treatment of opioid-induced constipation and is part of the exclusive worldwide license agreement announced on 21 September 2009, between AstraZeneca and Nektar Therapeutics (NKTR). |
|
| 08:56 EDT | | JCP | J.C. Penney announces successful tender, consent solicitation for debentures
Subscribe for More Information |
|
| 07:34 EDT | | BMY | UBS to host a conference
Subscribe for More Information |
|
| 07:24 EDT | | BMY, JNJ | Global Health Care to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 10:45 EDT |  | CAT | Caterpillar trends were weak in April, says Wells Fargo
Wells Fargo notes that Caterpillar's machines sales growth decelerated in April. The firm thinks that modest improvements in the company's overall trends may be mostly offset by North American machines sales deceleration, and it keeps a Market Perform rating on the shares. |
| |
|
|
|
|
